Visceral leishmaniasis: Host-parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host

International Journal of Infectious Diseases

Volumn 17, Issue 8, 2013, Pages

  Saporito, Laura ^a   Giammanco, Giovanni M ^a   De Grazia, Simona ^a   Colomba, Claudia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Asymptomatic infection; HIV; Immunocompetent host; Immunocompromised host; Leishmaniasis; Transplantation; Vector

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; INTERLEUKIN 10; INTERLEUKIN 4; MILTEFOSINE; PAROMOMYCIN;

ASYMPTOMATIC INFECTION; CLINICAL FEATURE; DEPRESSION; HOST PARASITE INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; MONOTHERAPY; REVIEW; VISCERAL LEISHMANIASIS;

EID: 84888084019     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.12.024     Document Type: Review

References (45)

1. Cohen C, Corazza F, De Mol P, Brasseur D. Leishmaniasis acquired in Belgium. Lancet 1991;338:128.
2. Singh S, Chaudhry VP, Wali JP. Transfusion-transmitted kala-azar in India. Transfusion 1996;36:848-9.
3. Kubar J, Quaranta JF, Aufeuvre JP, Marty P, Lelievre A, Le Fichoux Y. Transmission of Leishmania infantum by blood donors. Nat Med 1997;3:368.
4. Le Fichoux Y, Quaranta JF, Aufeuvre JP, Lelievre A, Marty P, Suffia I, et al. Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity of southern France. J Clin Microbiol 1999;37:1953-7.
5. Cruz I, Morales MA, Noguer I, Rodriguez A, Alvar J. Leishmania in discarded syringes from intravenous drug users. Lancet 2002;359:1124-5.
6. Figueiró-Filho EA, El Beitune P, Queiroz GT, Somensi RS, Morais NO, Dorval MEC, et al. Visceral leishmaniasis and pregnancy: analysis of cases reported in a central-western region of Brazil. Arch Gynecol Obstet 2008;278:13-6.
7. Meinecke CK, Schottelius J, Oskam L, Fleischer B. Congenital transmission of visceral leishmaniasis (kala azar) from an asymptomatic mother to her child. Pediatrics 1999;104:e65.
8. Pagliano P, Carannante N, Rossi M, Gramiccia M, Gradoni L, Faella FS, et al. Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature. J Antimicrob Chemother 2005;55:229-33.
9. Zinchuk A, Nadraga A. Congenital visceral leishmaniasis in Ukraine: case report. Ann Trop Paediatr 2010;30:161-4.
10. World Health Organization. Control of the leishmaniases. World Health Organ Tech Rep Ser 2010;(949):xii-xiii, 1-186.
11. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, et al., WHO Leishmaniasis Control Team. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012;7:e35671.
12. Rioux JA, Lanotte G, Serres E, Pratlong F, Bastien P, Perieres J. Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Ann Parasitol Hum Comp 1990;65:111-25.
13. Montalvo AM, Fraga J, Monzote L, Montano I, De Doncker S, Dujardin JC, et al. Heat-shock protein 70 PCR-RFLP: a universal simple tool for Leishmania species discrimination in the New and Old World. Parasitology 2010;137:1159-68.
14. Ben Abda I, de Monbrison F, Bousslimi N, Aoun K, Bouratbine A, Picot S. Advantages and limits of real-time PCR assay and PCR-restriction fragment length polymorphism for the identification of cutaneous Leishmania species in Tunisia. Trans R Soc Trop Med Hyg 2011;105:17-22.
15. Haouas N, Garrab S, Gorcii M, Khorchani H, Chargui N, Ravel C, et al. Development of a polymerase chain reaction-restriction fragment length polymorphism assay for Leishmania major/Leishmania killicki/Leishmania infantum discrimination from clinical samples, application in a Tunisian focus. Diagn Microbiol Infect Dis 2010;68:152-8.
16. Alborzi A, Rasouli M, Shamsizadeh A. Leishmania tropica-isolated patient with visceral leishmaniasis in southern Iran. Am J Trop Med Hyg 2006;74:306-7.
17. del Giudice P, Marty P, Lacour JP, Perrin C, Pratlong F, Haas H, et al. Cutaneous leishmaniasis due to Leishmania infantum. Case reports and literature review. Arch Dermatol 1998;134:193-8.
18. Pearson RD, De Queiroz Sousa A, Jeronimo SM. Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmaniasis. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases. Fifth ed., Philadelphia: Churchill Livingstone; 2000. p. 2831-45.
19. Oshaghi MA, Ravasan NM, Hide M, Javadian EA, Rassi Y, Sadraei J, et al. Phlebotomus perfiliewi transcaucasicus is circulating both Leishmania donovani and L. infantum in northwest Iran. Exp Parasitol 2009;123:218-25.
20. Volf P, Hostomska J, Rohousova I. Molecular crosstalks in Leishmania-sandflyhost relationships. Parasite 2008;15:237-43.
21. Dobson DE, Kamhawi S, Lawyer P, Turco SJ, Beverley SM, Sacks DL. Leishmania major survival in selective Phlebotomus papatasi sand fly vector requires a specific SCG-encoded lipophosphoglycan galactosylation pattern. PLoS Pathog 2010;6:e1001185.
22. Svárovská A, Ant TH, Seblová V, Jecná L, Beverley SM, Volf P. Leishmania major glycosylation mutants require phosphoglycans (lpg2-) but not lipophosphoglycan (lpg1-) for survival in permissive sand fly vectors. PLoS Negl Trop Dis 2010;4:e580.
23. Ready PD. Leishmaniasis emergence in Europe. Euro Surveill 2010;15:19505.
24. Dereure J, Vanwambeke SO, MaléP, Martinez S, Pratlong F, Balard Y, et al. The potential effects of global warming on changes in canine leishmaniasis in a focus outside the classical area of the disease in southern France. Vector Borne Zoonotic Dis 2009;9:687-94.
25. Dujardin JC, Campino L, Cañavate C, Dedet JP, Gradoni L, Soteriadou K, et al. Spread of vector-borne diseases and neglect of leishmaniasis, Europe. Emerg Infect Dis 2008;14:1013-8.
26. Fischer D, Thomas SM, Beierkuhnlein C. Temperature-derived potential for the establishment of phlebotomine sandflies and visceral leishmaniasis in Germany. Geospat Health 2010;5:59-69.
27. McMahon-Pratt D, Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev 2004;201:206-24.
28. Sakthianandeswaren A, Foote SJ, Handman E. The role of host genetics in leishmaniasis. Trends Parasitol 2009;25:383-91.
29. Blackwell JM, Fakiola M, Ibrahim ME, Jamieson SE, Jeronimo SB, Miller EN, et al. Genetics and visceral leishmaniasis: of mice and man. Parasite Immunol 2009;31:254-66.
30. Domínguez M, Moreno I, Aizpurua C, Toraño A. Early mechanisms of Leishmania infection in human blood. Microbes Infect 2003;5:507-13.
31. Maurer M, Dondji B, von Stebut E. What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis. Med Microbiol Immunol 2009;198:137-46.
32. Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993;178:567-77.
33. Akuffo HO, Britton SF. Contribution of non-Leishmania-specific immunity to resistance to Leishmania infection in humans. Clin Exp Immunol 1992;87:58-64.
34. Stanley AC, Engwerda CR. Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol 2007;85:138-47.
35. Oghumu S, Lezama-Dávila CM, Isaac-Márquez AP, Satoskar AR. Role of chemokines in regulation of immunity against leishmaniasis. Exp Parasitol 2010;126:389-96.
36. Lipoldová M, Svobodová M, Havelková H, Krulová M, Badalová J, Nohýnková E, et al. Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis. Immunogenetics 2002;54:174-83.
37. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989;169:59-72.
38. Reed SG, Scott P. T-cell and cytokine responses in leishmaniasis. Curr Opin Immunol 1993;5:524-31.
39. Mansueto P, Vitale G, Di Lorenzo G, Rini GB, Mansueto S, Cillari E. Immunopathology of leishmaniasis: an update. Int J Immunopathol Pharmacol 2007;20:435-45.
40. Sundar S, Reed SG, Sharma S, Mehrotra A, Murray HW. Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg 1997;56:522-5.
41. Ezra N, Ochoa MT, Craft N. Human immunodeficiency virus and leishmaniasis. J Glob Infect Dis 2010;2:248-57.
42. Ruiz JH, Becker I. CD8 cytotoxic T cells in cutaneous leishmaniasis. Parasite Immunol 2007;29:671-8.
43. Sotiropoulos G, Wilbur B. Two cases of cutaneous leishmaniasis presenting to the emergency department as chronic ulcers. J Emerg Med 2001;20:353-6.
44. Amini H. Cutaneous lesions with very long duration as a complication of leishmanization. Iran J Public Health 1991;20:43-9.
45. Chrusciak-Talhari A, Ribeiro-Rodrigues R, Talhari C, Silva Jr RM, Ferreira LC, Botileiro SF, et al. Tegumentary leishmaniasis as the cause of immune reconstitution inflammatory syndrome in a patient co-infected with human immunodeficiency virus and Leishmania guyanensis. Am J Trop Med Hyg 2009;81:559-64.